nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—RRM2—uterine cancer	0.766	1	CbGaD
Gallium nitrate—TF—semen—uterine cancer	0.00984	0.102	CbGeAlD
Gallium nitrate—IL1B—artery—uterine cancer	0.00536	0.0558	CbGeAlD
Gallium nitrate—TF—exocrine gland—uterine cancer	0.00416	0.0434	CbGeAlD
Gallium nitrate—ATP6V1B2—myometrium—uterine cancer	0.00354	0.0369	CbGeAlD
Gallium nitrate—ATP6V1B2—uterine cervix—uterine cancer	0.00275	0.0287	CbGeAlD
Gallium nitrate—IL1B—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.617	CbGdCrCtD
Gallium nitrate—ATP6V1B2—decidua—uterine cancer	0.00262	0.0273	CbGeAlD
Gallium nitrate—IL1B—myometrium—uterine cancer	0.00259	0.027	CbGeAlD
Gallium nitrate—ATP6V1B2—renal system—uterine cancer	0.00258	0.0268	CbGeAlD
Gallium nitrate—ATP6V1B2—endometrium—uterine cancer	0.00249	0.0259	CbGeAlD
Gallium nitrate—ATP6V1B2—mammalian vulva—uterine cancer	0.00241	0.0251	CbGeAlD
Gallium nitrate—ATP6V1B2—uterus—uterine cancer	0.00229	0.0239	CbGeAlD
Gallium nitrate—RRM2—myometrium—uterine cancer	0.00228	0.0238	CbGeAlD
Gallium nitrate—BGLAP—renal system—uterine cancer	0.0022	0.023	CbGeAlD
Gallium nitrate—Optic neuritis—Progesterone—uterine cancer	0.00213	0.0453	CcSEcCtD
Gallium nitrate—ATP6V1B2—female reproductive system—uterine cancer	0.00206	0.0215	CbGeAlD
Gallium nitrate—IL1B—epithelium—uterine cancer	0.00203	0.0212	CbGeAlD
Gallium nitrate—IL1B—smooth muscle tissue—uterine cancer	0.00196	0.0204	CbGeAlD
Gallium nitrate—Optic neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.041	CcSEcCtD
Gallium nitrate—IL1B—decidua—uterine cancer	0.00192	0.02	CbGeAlD
Gallium nitrate—IL1B—renal system—uterine cancer	0.00188	0.0196	CbGeAlD
Gallium nitrate—ATP6V1B2—female gonad—uterine cancer	0.00188	0.0196	CbGeAlD
Gallium nitrate—ATP6V1B2—vagina—uterine cancer	0.00187	0.0194	CbGeAlD
Gallium nitrate—IL1B—endometrium—uterine cancer	0.00182	0.019	CbGeAlD
Gallium nitrate—TF—epithelium—uterine cancer	0.00181	0.0189	CbGeAlD
Gallium nitrate—TF—uterine cervix—uterine cancer	0.0018	0.0187	CbGeAlD
Gallium nitrate—RRM2—uterine cervix—uterine cancer	0.00177	0.0185	CbGeAlD
Gallium nitrate—BGLAP—female reproductive system—uterine cancer	0.00176	0.0184	CbGeAlD
Gallium nitrate—RRM2—decidua—uterine cancer	0.00169	0.0176	CbGeAlD
Gallium nitrate—TF—renal system—uterine cancer	0.00168	0.0175	CbGeAlD
Gallium nitrate—IL1B—uterus—uterine cancer	0.00168	0.0175	CbGeAlD
Gallium nitrate—RRM2—renal system—uterine cancer	0.00166	0.0173	CbGeAlD
Gallium nitrate—IL1B—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.383	CbGdCrCtD
Gallium nitrate—RRM2—endometrium—uterine cancer	0.0016	0.0167	CbGeAlD
Gallium nitrate—RRM2—mammalian vulva—uterine cancer	0.00155	0.0162	CbGeAlD
Gallium nitrate—Neoplasm malignant—Progesterone—uterine cancer	0.00153	0.0326	CcSEcCtD
Gallium nitrate—IL1B—female reproductive system—uterine cancer	0.00151	0.0157	CbGeAlD
Gallium nitrate—TF—uterus—uterine cancer	0.0015	0.0156	CbGeAlD
Gallium nitrate—RRM2—uterus—uterine cancer	0.00148	0.0154	CbGeAlD
Gallium nitrate—Hypocalcaemia—Progesterone—uterine cancer	0.00143	0.0304	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.0296	CcSEcCtD
Gallium nitrate—IL1B—female gonad—uterine cancer	0.00137	0.0143	CbGeAlD
Gallium nitrate—IL1B—vagina—uterine cancer	0.00136	0.0142	CbGeAlD
Gallium nitrate—TF—female reproductive system—uterine cancer	0.00135	0.014	CbGeAlD
Gallium nitrate—RRM2—female reproductive system—uterine cancer	0.00133	0.0139	CbGeAlD
Gallium nitrate—TF—female gonad—uterine cancer	0.00122	0.0128	CbGeAlD
Gallium nitrate—TF—vagina—uterine cancer	0.00122	0.0127	CbGeAlD
Gallium nitrate—RRM2—female gonad—uterine cancer	0.00121	0.0126	CbGeAlD
Gallium nitrate—ATP6V1B2—lymph node—uterine cancer	0.00121	0.0126	CbGeAlD
Gallium nitrate—RRM2—vagina—uterine cancer	0.0012	0.0125	CbGeAlD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—BIRC5—uterine cancer	0.00117	0.0134	CbGpPWpGaD
Gallium nitrate—Optic neuritis—Etoposide—uterine cancer	0.00109	0.0232	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—MAP3K4—uterine cancer	0.00107	0.0123	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—MME—uterine cancer	0.00103	0.0118	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—STK11—uterine cancer	0.00102	0.0118	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—uterine cancer	0.00102	0.0117	CbGpPWpGaD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—SOCS3—uterine cancer	0.00101	0.0117	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—SOCS3—uterine cancer	0.00101	0.0117	CbGpPWpGaD
Gallium nitrate—Hypocalcaemia—Dactinomycin—uterine cancer	0.00101	0.0215	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.001	0.0116	CbGpPWpGaD
Gallium nitrate—BGLAP—FGF signaling pathway—FGFR2—uterine cancer	0.001	0.0115	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—GPX3—uterine cancer	0.000999	0.0115	CbGpPWpGaD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000909	0.0104	CbGpPWpGaD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—CCL2—uterine cancer	0.000901	0.0104	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—uterine cancer	0.000889	0.0102	CbGpPWpGaD
Gallium nitrate—IL1B—lymph node—uterine cancer	0.000883	0.0092	CbGeAlD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—INHBA—uterine cancer	0.000871	0.01	CbGpPWpGaD
Gallium nitrate—BGLAP—FGF signaling pathway—MET—uterine cancer	0.00086	0.00988	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—uterine cancer	0.000806	0.00927	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—FGFR2—uterine cancer	0.000798	0.00918	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—GPX3—uterine cancer	0.000793	0.00912	CbGpPWpGaD
Gallium nitrate—TF—lymph node—uterine cancer	0.000787	0.0082	CbGeAlD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—CALD1—uterine cancer	0.000783	0.009	CbGpPWpGaD
Gallium nitrate—RRM2—lymph node—uterine cancer	0.000778	0.0081	CbGeAlD
Gallium nitrate—BGLAP—FGF signaling pathway—CDH1—uterine cancer	0.000745	0.00856	CbGpPWpGaD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—MET—uterine cancer	0.000732	0.00842	CbGpPWpGaD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.00072	0.00828	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Carboplatin—uterine cancer	0.000702	0.015	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—uterine cancer	0.000691	0.00795	CbGpPWpGaD
Gallium nitrate—Lethargy—Dactinomycin—uterine cancer	0.000685	0.0146	CcSEcCtD
Gallium nitrate—Blindness—Epirubicin—uterine cancer	0.000677	0.0144	CcSEcCtD
Gallium nitrate—Hypothermia—Epirubicin—uterine cancer	0.000669	0.0143	CcSEcCtD
Gallium nitrate—Body temperature decreased—Epirubicin—uterine cancer	0.000669	0.0143	CcSEcCtD
Gallium nitrate—BGLAP—Notch-mediated HES/HEY network—CDKN1B—uterine cancer	0.00065	0.00748	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Progesterone—uterine cancer	0.000647	0.0138	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Epirubicin—uterine cancer	0.000645	0.0137	CcSEcCtD
Gallium nitrate—IL1B—IL23-mediated signaling events—CCL2—uterine cancer	0.000637	0.00733	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.00063	0.00724	CbGpPWpGaD
Gallium nitrate—Blindness—Doxorubicin—uterine cancer	0.000627	0.0134	CcSEcCtD
Gallium nitrate—Hypothermia—Doxorubicin—uterine cancer	0.000619	0.0132	CcSEcCtD
Gallium nitrate—Body temperature decreased—Doxorubicin—uterine cancer	0.000619	0.0132	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000619	0.00712	CbGpPWpGaD
Gallium nitrate—Tinnitus—Progesterone—uterine cancer	0.000612	0.013	CcSEcCtD
Gallium nitrate—Optic neuritis—Epirubicin—uterine cancer	0.00061	0.013	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IRF1—uterine cancer	0.000601	0.00691	CbGpPWpGaD
Gallium nitrate—Hypophosphataemia—Doxorubicin—uterine cancer	0.000597	0.0127	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—HMGA1—uterine cancer	0.000589	0.00677	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.0125	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—SOCS3—uterine cancer	0.000577	0.00663	CbGpPWpGaD
Gallium nitrate—Erythema—Progesterone—uterine cancer	0.000572	0.0122	CcSEcCtD
Gallium nitrate—BGLAP—Notch-mediated HES/HEY network—EP300—uterine cancer	0.000571	0.00656	CbGpPWpGaD
Gallium nitrate—Optic neuritis—Doxorubicin—uterine cancer	0.000564	0.012	CcSEcCtD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—CDKN2A—uterine cancer	0.00056	0.00643	CbGpPWpGaD
Gallium nitrate—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000555	0.0118	CcSEcCtD
Gallium nitrate—Anaemia—Progesterone—uterine cancer	0.000528	0.0113	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000528	0.00607	CbGpPWpGaD
Gallium nitrate—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000518	0.011	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—MTHFR—uterine cancer	0.000513	0.00589	CbGpPWpGaD
Gallium nitrate—TF—EPHB forward signaling—NRAS—uterine cancer	0.0005	0.00575	CbGpPWpGaD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—CDKN1B—uterine cancer	0.000496	0.0057	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000493	0.00567	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Epirubicin—uterine cancer	0.00049	0.0104	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000487	0.0056	CbGpPWpGaD
Gallium nitrate—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000479	0.0102	CcSEcCtD
Gallium nitrate—Confusional state—Progesterone—uterine cancer	0.00047	0.01	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—CCL2—uterine cancer	0.000464	0.00534	CbGpPWpGaD
Gallium nitrate—Tachycardia—Progesterone—uterine cancer	0.000455	0.0097	CcSEcCtD
Gallium nitrate—Pleural effusion—Doxorubicin—uterine cancer	0.000453	0.00965	CcSEcCtD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—PIK3CA—uterine cancer	0.000452	0.0052	CbGpPWpGaD
Gallium nitrate—Neoplasm malignant—Epirubicin—uterine cancer	0.000439	0.00936	CcSEcCtD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—EP300—uterine cancer	0.000435	0.005	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—SOCS3—uterine cancer	0.000431	0.00495	CbGpPWpGaD
Gallium nitrate—TF—EPHB forward signaling—KRAS—uterine cancer	0.00043	0.00495	CbGpPWpGaD
Gallium nitrate—TF—Differentiation Pathway—VEGFA—uterine cancer	0.000429	0.00493	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	0.000427	0.0049	CbGpPWpGaD
Gallium nitrate—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000426	0.00908	CcSEcCtD
Gallium nitrate—Paraesthesia—Progesterone—uterine cancer	0.000419	0.00893	CcSEcCtD
Gallium nitrate—Dyspnoea—Progesterone—uterine cancer	0.000416	0.00886	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000413	0.00475	CbGpPWpGaD
Gallium nitrate—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000413	0.00879	CcSEcCtD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—HRAS—uterine cancer	0.000412	0.00474	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—ESR1—uterine cancer	0.000411	0.00473	CbGpPWpGaD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—YWHAE—uterine cancer	0.000411	0.00473	CbGpPWpGaD
Gallium nitrate—Hypocalcaemia—Epirubicin—uterine cancer	0.00041	0.00873	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IGF1R—uterine cancer	0.00041	0.00471	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000409	0.0047	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000407	0.00468	CbGpPWpGaD
Gallium nitrate—Neoplasm malignant—Doxorubicin—uterine cancer	0.000406	0.00866	CcSEcCtD
Gallium nitrate—Erythema—Dactinomycin—uterine cancer	0.000404	0.00861	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—CCL2—uterine cancer	0.000401	0.00461	CbGpPWpGaD
Gallium nitrate—Constipation—Progesterone—uterine cancer	0.000399	0.0085	CcSEcCtD
Gallium nitrate—TF—EPHB forward signaling—PIK3CA—uterine cancer	0.000395	0.00454	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MLH3—uterine cancer	0.000385	0.00443	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—SMAD3—uterine cancer	0.000385	0.00443	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Progesterone—uterine cancer	0.000384	0.00819	CcSEcCtD
Gallium nitrate—IL1B—IFN-gamma pathway—EP300—uterine cancer	0.000383	0.00441	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—NRAS—uterine cancer	0.000381	0.00439	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.00809	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Doxorubicin—uterine cancer	0.000379	0.00807	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—PIK3CA—uterine cancer	0.000378	0.00435	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000378	0.00434	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000377	0.00803	CcSEcCtD
Gallium nitrate—Anaemia—Dactinomycin—uterine cancer	0.000373	0.00796	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—AKR1B10—uterine cancer	0.000372	0.00428	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Progesterone—uterine cancer	0.000369	0.00786	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—EP300—uterine cancer	0.000366	0.00421	CbGpPWpGaD
Gallium nitrate—TF—EPHB forward signaling—HRAS—uterine cancer	0.000366	0.0042	CbGpPWpGaD
Gallium nitrate—BGLAP—Interleukin-11 Signaling Pathway—AKT1—uterine cancer	0.000364	0.00418	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000363	0.00417	CbGpPWpGaD
Gallium nitrate—Leukopenia—Dactinomycin—uterine cancer	0.000362	0.00771	CcSEcCtD
Gallium nitrate—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.0077	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000351	0.00404	CbGpPWpGaD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—EP300—uterine cancer	0.000351	0.00403	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000348	0.00742	CcSEcCtD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—TP53—uterine cancer	0.000345	0.00397	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Progesterone—uterine cancer	0.000344	0.00732	CcSEcCtD
Gallium nitrate—Coma—Epirubicin—uterine cancer	0.000343	0.0073	CcSEcCtD
Gallium nitrate—IL1B—IL1-mediated signaling events—PIK3CA—uterine cancer	0.000342	0.00393	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000339	0.0039	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000334	0.00712	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	0.000332	0.00382	CbGpPWpGaD
Gallium nitrate—Pruritus—Progesterone—uterine cancer	0.00033	0.00703	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—CDKN2A—uterine cancer	0.000329	0.00378	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—KRAS—uterine cancer	0.000328	0.00377	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—PIK3CA—uterine cancer	0.00032	0.00367	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Progesterone—uterine cancer	0.000319	0.0068	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—CCL2—uterine cancer	0.000319	0.00366	CbGpPWpGaD
Gallium nitrate—Coma—Doxorubicin—uterine cancer	0.000317	0.00675	CcSEcCtD
Gallium nitrate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000311	0.00664	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—AKT1—uterine cancer	0.000309	0.00355	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—RNF43—uterine cancer	0.000309	0.00355	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—ERBB2—uterine cancer	0.000302	0.00347	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—PIK3CA—uterine cancer	0.000302	0.00347	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000301	0.00346	CbGpPWpGaD
Gallium nitrate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000299	0.00637	CcSEcCtD
Gallium nitrate—Vomiting—Progesterone—uterine cancer	0.000297	0.00632	CcSEcCtD
Gallium nitrate—Renal failure acute—Epirubicin—uterine cancer	0.000295	0.00628	CcSEcCtD
Gallium nitrate—Rash—Progesterone—uterine cancer	0.000294	0.00627	CcSEcCtD
Gallium nitrate—Dermatitis—Progesterone—uterine cancer	0.000294	0.00626	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—CDKN1B—uterine cancer	0.000291	0.00334	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000289	0.00616	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—VEGFA—uterine cancer	0.000285	0.00327	CbGpPWpGaD
Gallium nitrate—IL1B—IFN-gamma pathway—PIK3CA—uterine cancer	0.000283	0.00326	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—HRAS—uterine cancer	0.000279	0.00321	CbGpPWpGaD
Gallium nitrate—Lethargy—Epirubicin—uterine cancer	0.000278	0.00592	CcSEcCtD
Gallium nitrate—Nausea—Progesterone—uterine cancer	0.000277	0.0059	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—CXCL8—uterine cancer	0.000275	0.00316	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IRF1—uterine cancer	0.000274	0.00315	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Doxorubicin—uterine cancer	0.000273	0.00581	CcSEcCtD
Gallium nitrate—Feeling abnormal—Dactinomycin—uterine cancer	0.000272	0.00579	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000271	0.00312	CbGpPWpGaD
Gallium nitrate—Anaemia—Etoposide—uterine cancer	0.00027	0.00576	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—NDC80—uterine cancer	0.000269	0.0031	CbGpPWpGaD
Gallium nitrate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000269	0.00573	CcSEcCtD
Gallium nitrate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000267	0.00568	CcSEcCtD
Gallium nitrate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000266	0.00567	CcSEcCtD
Gallium nitrate—Leukopenia—Etoposide—uterine cancer	0.000262	0.00558	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—TP53—uterine cancer	0.000262	0.00301	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—AKR1B10—uterine cancer	0.000261	0.003	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Dactinomycin—uterine cancer	0.000261	0.00555	CcSEcCtD
Gallium nitrate—Lethargy—Doxorubicin—uterine cancer	0.000257	0.00548	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000256	0.00295	CbGpPWpGaD
Gallium nitrate—RRM2—E2F transcription factor network—EP300—uterine cancer	0.000255	0.00294	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—AKR1C1—uterine cancer	0.000254	0.00292	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000253	0.00291	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CCL2—uterine cancer	0.000252	0.0029	CbGpPWpGaD
Gallium nitrate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000251	0.00535	CcSEcCtD
Gallium nitrate—Hypersensitivity—Dactinomycin—uterine cancer	0.000243	0.00518	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN2A—uterine cancer	0.000241	0.00277	CbGpPWpGaD
Gallium nitrate—Confusional state—Etoposide—uterine cancer	0.000241	0.00513	CcSEcCtD
Gallium nitrate—Tachycardia—Etoposide—uterine cancer	0.000233	0.00496	CcSEcCtD
Gallium nitrate—IL1B—IFN-gamma pathway—AKT1—uterine cancer	0.000232	0.00266	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—POLD1—uterine cancer	0.000229	0.00263	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Dactinomycin—uterine cancer	0.000226	0.00481	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—CXCL8—uterine cancer	0.000224	0.00257	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—VEGFA—uterine cancer	0.000223	0.00256	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	0.000221	0.00254	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IRF1—uterine cancer	0.00022	0.00253	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—DCN—uterine cancer	0.00022	0.00253	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CXCL8—uterine cancer	0.000219	0.00251	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RNF43—uterine cancer	0.000216	0.00248	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Etoposide—uterine cancer	0.000214	0.00457	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN1B—uterine cancer	0.000214	0.00246	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Etoposide—uterine cancer	0.000213	0.00453	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—AKT1—uterine cancer	0.000212	0.00244	CbGpPWpGaD
Gallium nitrate—RRM2—G1/S Transition—CDKN1B—uterine cancer	0.000211	0.00243	CbGpPWpGaD
Gallium nitrate—Vomiting—Dactinomycin—uterine cancer	0.00021	0.00447	CcSEcCtD
Gallium nitrate—Rash—Dactinomycin—uterine cancer	0.000208	0.00443	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000206	0.00236	CbGpPWpGaD
Gallium nitrate—Constipation—Etoposide—uterine cancer	0.000204	0.00435	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—SOCS3—uterine cancer	0.000201	0.00231	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000201	0.00231	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CXCL8—uterine cancer	0.000199	0.00229	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—INHBA—uterine cancer	0.000198	0.00227	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—PTEN—uterine cancer	0.000197	0.00226	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Etoposide—uterine cancer	0.000197	0.00419	CcSEcCtD
Gallium nitrate—Nausea—Dactinomycin—uterine cancer	0.000196	0.00417	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—AKR1C3—uterine cancer	0.000196	0.00225	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—TP53—uterine cancer	0.000195	0.00224	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CDKN1B—uterine cancer	0.000195	0.00224	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HMGA1—uterine cancer	0.000191	0.00219	CbGpPWpGaD
Gallium nitrate—IL1B—IL-1 signaling pathway—AKT1—uterine cancer	0.00019	0.00219	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.00019	0.00218	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Etoposide—uterine cancer	0.000189	0.00402	CcSEcCtD
Gallium nitrate—Oedema peripheral—Epirubicin—uterine cancer	0.000186	0.00395	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—AKR1C1—uterine cancer	0.000178	0.00205	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000178	0.00205	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000176	0.00203	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Etoposide—uterine cancer	0.000176	0.00375	CcSEcCtD
Gallium nitrate—Tinnitus—Epirubicin—uterine cancer	0.000176	0.00374	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—CXCL8—uterine cancer	0.000175	0.00201	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—FBXW7—uterine cancer	0.000174	0.002	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—SRD5A2—uterine cancer	0.000173	0.00199	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NDUFB11—uterine cancer	0.000173	0.00199	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Doxorubicin—uterine cancer	0.000172	0.00366	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—NRAS—uterine cancer	0.000172	0.00197	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000171	0.00197	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MLH1—uterine cancer	0.00017	0.00195	CbGpPWpGaD
Gallium nitrate—Pruritus—Etoposide—uterine cancer	0.000169	0.0036	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—TP53—uterine cancer	0.000169	0.00194	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—HRAS—uterine cancer	0.000168	0.00193	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000167	0.00192	CbGpPWpGaD
Gallium nitrate—Erythema—Epirubicin—uterine cancer	0.000164	0.00349	CcSEcCtD
Gallium nitrate—Diarrhoea—Etoposide—uterine cancer	0.000163	0.00348	CcSEcCtD
Gallium nitrate—Tinnitus—Doxorubicin—uterine cancer	0.000162	0.00346	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000159	0.00183	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000159	0.00183	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—YWHAE—uterine cancer	0.000153	0.00176	CbGpPWpGaD
Gallium nitrate—Vomiting—Etoposide—uterine cancer	0.000152	0.00323	CcSEcCtD
Gallium nitrate—Erythema—Doxorubicin—uterine cancer	0.000152	0.00323	CcSEcCtD
Gallium nitrate—Anaemia—Epirubicin—uterine cancer	0.000152	0.00323	CcSEcCtD
Gallium nitrate—Rash—Etoposide—uterine cancer	0.00015	0.00321	CcSEcCtD
Gallium nitrate—Dermatitis—Etoposide—uterine cancer	0.00015	0.0032	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—AKT1—uterine cancer	0.000148	0.00171	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—KRAS—uterine cancer	0.000148	0.0017	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000147	0.00169	CbGpPWpGaD
Gallium nitrate—Leukopenia—Epirubicin—uterine cancer	0.000147	0.00313	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—HRAS—uterine cancer	0.000145	0.00167	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—PIK3CA—uterine cancer	0.000142	0.00163	CbGpPWpGaD
Gallium nitrate—Nausea—Etoposide—uterine cancer	0.000142	0.00302	CcSEcCtD
Gallium nitrate—Anaemia—Doxorubicin—uterine cancer	0.00014	0.00299	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—AKR1C3—uterine cancer	0.000137	0.00157	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000137	0.00157	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CDKN2B—uterine cancer	0.000137	0.00157	CbGpPWpGaD
Gallium nitrate—Leukopenia—Doxorubicin—uterine cancer	0.000136	0.00289	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—PIK3CA—uterine cancer	0.000136	0.00156	CbGpPWpGaD
Gallium nitrate—Confusional state—Epirubicin—uterine cancer	0.000135	0.00287	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TP53—uterine cancer	0.000134	0.00154	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PGR—uterine cancer	0.000133	0.00153	CbGpPWpGaD
Gallium nitrate—Tachycardia—Epirubicin—uterine cancer	0.000131	0.00278	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000129	0.00149	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000129	0.00148	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—HRAS—uterine cancer	0.000128	0.00148	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—AKT1—uterine cancer	0.000128	0.00147	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—YWHAE—uterine cancer	0.000127	0.00146	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.000126	0.00145	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—HRAS—uterine cancer	0.000126	0.00144	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—AKR1B1—uterine cancer	0.000125	0.00144	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—STAR—uterine cancer	0.000125	0.00144	CbGpPWpGaD
Gallium nitrate—Confusional state—Doxorubicin—uterine cancer	0.000125	0.00266	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—SMAD3—uterine cancer	0.000125	0.00143	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TP53—uterine cancer	0.000122	0.00141	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—FBXW7—uterine cancer	0.000122	0.0014	CbGpPWpGaD
Gallium nitrate—Tachycardia—Doxorubicin—uterine cancer	0.000121	0.00257	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NRAS—uterine cancer	0.00012	0.00139	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Epirubicin—uterine cancer	0.00012	0.00256	CcSEcCtD
Gallium nitrate—Dyspnoea—Epirubicin—uterine cancer	0.000119	0.00254	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—FGFR2—uterine cancer	0.000119	0.00137	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—AKT1—uterine cancer	0.000116	0.00133	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2B—uterine cancer	0.000115	0.00132	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MTHFR—uterine cancer	0.000115	0.00132	CbGpPWpGaD
Gallium nitrate—Constipation—Epirubicin—uterine cancer	0.000114	0.00244	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000111	0.00128	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Doxorubicin—uterine cancer	0.000111	0.00237	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—PIK3CA—uterine cancer	0.000111	0.00127	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Doxorubicin—uterine cancer	0.00011	0.00235	CcSEcCtD
Gallium nitrate—Feeling abnormal—Epirubicin—uterine cancer	0.00011	0.00235	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—STK11—uterine cancer	0.000107	0.00123	CbGpPWpGaD
Gallium nitrate—Constipation—Doxorubicin—uterine cancer	0.000106	0.00226	CcSEcCtD
Gallium nitrate—Body temperature increased—Epirubicin—uterine cancer	0.000106	0.00225	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—KRAS—uterine cancer	0.000104	0.00119	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Doxorubicin—uterine cancer	0.000102	0.00217	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SOCS3—uterine cancer	9.99e-05	0.00115	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—BIRC5—uterine cancer	9.94e-05	0.00114	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	9.87e-05	0.00113	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Epirubicin—uterine cancer	9.86e-05	0.0021	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—POLD1—uterine cancer	9.84e-05	0.00113	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Doxorubicin—uterine cancer	9.79e-05	0.00208	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CDKN2B—uterine cancer	9.57e-05	0.0011	CbGpPWpGaD
Gallium nitrate—Pruritus—Epirubicin—uterine cancer	9.47e-05	0.00202	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IGF1R—uterine cancer	9.29e-05	0.00107	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TP53—uterine cancer	9.22e-05	0.00106	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—AKR1C1—uterine cancer	9.2e-05	0.00106	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Epirubicin—uterine cancer	9.15e-05	0.00195	CcSEcCtD
Gallium nitrate—Hypersensitivity—Doxorubicin—uterine cancer	9.12e-05	0.00194	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	9.06e-05	0.00104	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IRF1—uterine cancer	8.95e-05	0.00103	CbGpPWpGaD
Gallium nitrate—Pruritus—Doxorubicin—uterine cancer	8.76e-05	0.00187	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SMAD3—uterine cancer	8.73e-05	0.001	CbGpPWpGaD
Gallium nitrate—Vomiting—Epirubicin—uterine cancer	8.51e-05	0.00181	CcSEcCtD
Gallium nitrate—Diarrhoea—Doxorubicin—uterine cancer	8.47e-05	0.0018	CcSEcCtD
Gallium nitrate—Rash—Epirubicin—uterine cancer	8.44e-05	0.0018	CcSEcCtD
Gallium nitrate—Dermatitis—Epirubicin—uterine cancer	8.43e-05	0.0018	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—FGFR2—uterine cancer	8.33e-05	0.000958	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—AKT1—uterine cancer	8.06e-05	0.000927	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—FBXW7—uterine cancer	8.02e-05	0.000922	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—NRAS—uterine cancer	8.01e-05	0.000921	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—DCN—uterine cancer	7.96e-05	0.000916	CbGpPWpGaD
Gallium nitrate—Nausea—Epirubicin—uterine cancer	7.95e-05	0.00169	CcSEcCtD
Gallium nitrate—Vomiting—Doxorubicin—uterine cancer	7.87e-05	0.00168	CcSEcCtD
Gallium nitrate—Rash—Doxorubicin—uterine cancer	7.81e-05	0.00166	CcSEcCtD
Gallium nitrate—Dermatitis—Doxorubicin—uterine cancer	7.8e-05	0.00166	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—AKT1—uterine cancer	7.78e-05	0.000895	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CYP11A1—uterine cancer	7.5e-05	0.000863	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ERBB2—uterine cancer	7.47e-05	0.000859	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2A—uterine cancer	7.37e-05	0.000847	CbGpPWpGaD
Gallium nitrate—Nausea—Doxorubicin—uterine cancer	7.35e-05	0.00157	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ESR1—uterine cancer	7.13e-05	0.000819	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—AKR1C3—uterine cancer	7.09e-05	0.000815	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CDKN1B—uterine cancer	6.92e-05	0.000795	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—KRAS—uterine cancer	6.89e-05	0.000792	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—EP300—uterine cancer	6.88e-05	0.00079	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2A—uterine cancer	6.59e-05	0.000757	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—SOCS3—uterine cancer	6.57e-05	0.000755	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CTNNB1—uterine cancer	6.54e-05	0.000751	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN1B—uterine cancer	6.52e-05	0.00075	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—VEGFA—uterine cancer	6.51e-05	0.000749	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—NRAS—uterine cancer	6.43e-05	0.00074	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PTEN—uterine cancer	6.37e-05	0.000732	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	6.33e-05	0.000728	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CCL2—uterine cancer	6.27e-05	0.000721	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—EP300—uterine cancer	6.08e-05	0.000698	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HRAS—uterine cancer	5.86e-05	0.000673	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN1B—uterine cancer	5.83e-05	0.000671	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—EP300—uterine cancer	5.73e-05	0.000659	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—NRAS—uterine cancer	5.68e-05	0.000653	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—KRAS—uterine cancer	5.54e-05	0.000636	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—STK11—uterine cancer	5.52e-05	0.000635	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CYP19A1—uterine cancer	5.52e-05	0.000635	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—FGFR2—uterine cancer	5.47e-05	0.000629	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ERBB2—uterine cancer	5.23e-05	0.000601	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—EP300—uterine cancer	5.12e-05	0.000589	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—PIK3CA—uterine cancer	5.09e-05	0.000585	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CXCL8—uterine cancer	4.96e-05	0.00057	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TP53—uterine cancer	4.92e-05	0.000566	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—KRAS—uterine cancer	4.89e-05	0.000562	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CDKN1B—uterine cancer	4.84e-05	0.000557	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—HRAS—uterine cancer	4.71e-05	0.000541	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CTNNB1—uterine cancer	4.58e-05	0.000526	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PIK3CA—uterine cancer	4.49e-05	0.000517	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTEN—uterine cancer	4.46e-05	0.000513	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—EP300—uterine cancer	4.25e-05	0.000489	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HRAS—uterine cancer	4.16e-05	0.000478	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—AKT1—uterine cancer	4.16e-05	0.000478	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—MTHFR—uterine cancer	4.15e-05	0.000477	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CDH1—uterine cancer	4.07e-05	0.000468	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—VEGFA—uterine cancer	4.03e-05	0.000463	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NRAS—uterine cancer	3.98e-05	0.000458	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—AKT1—uterine cancer	3.67e-05	0.000422	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TP53—uterine cancer	3.67e-05	0.000421	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ERBB2—uterine cancer	3.44e-05	0.000395	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—KRAS—uterine cancer	3.43e-05	0.000394	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CDKN1B—uterine cancer	3.18e-05	0.000366	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PIK3CA—uterine cancer	3.15e-05	0.000362	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TP53—uterine cancer	3.04e-05	0.00035	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CTNNB1—uterine cancer	3.01e-05	0.000346	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PTEN—uterine cancer	2.93e-05	0.000337	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HRAS—uterine cancer	2.91e-05	0.000335	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—EP300—uterine cancer	2.8e-05	0.000321	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—NRAS—uterine cancer	2.62e-05	0.000301	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—AKT1—uterine cancer	2.57e-05	0.000296	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PTEN—uterine cancer	2.31e-05	0.000265	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KRAS—uterine cancer	2.25e-05	0.000259	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—EP300—uterine cancer	2.2e-05	0.000253	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PIK3CA—uterine cancer	2.07e-05	0.000238	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HRAS—uterine cancer	1.91e-05	0.00022	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—AKT1—uterine cancer	1.69e-05	0.000194	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PIK3CA—uterine cancer	1.63e-05	0.000187	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—AKT1—uterine cancer	1.33e-05	0.000153	CbGpPWpGaD
